The ninth entry in the mainline Resident Evil series is fast approaching, but if you’re thinking that it could be the ideal point to jump in for the first time, you’ll almost certainly be left ...

Sci-Fi Shows Fallout season 3 release date speculation, cast, news, and everything else we know Sci-Fi Shows Fallout season 2 release date, cast, reviews, and everything we else we know Sci-Fi Shows ...

Note: This story contains spoilers from “His & Hers” Episode 6. For series star and executive producer, Tessa Thompson, the toughest part of crafting the “His & Hers” twisty ending was ensuring it ...

Netflix’s latest Korean blockbuster The Great Flood has surged to the top of the platform’s global charts for nonglobal films, but audiences are divided over its cryptic ending and philosophical twist ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

There's a huge twist at the ending of Emma Stone's new movie Bugonia, and it needs to be discussed. After being kidnapped and trapped in a basement for most of the film, things finally come to a head ...

Management reaffirmed guidance for 2025 on an expense base of less than $450 million, "excluding all of the partnership inflows." For 2026, guidance was also reaffirmed at less than $390 million.

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...